Skip to content
Search

Latest Stories

PDA assures support for pharmacists as TESCO confirms pharmacy closures

PDA warns that Tesco pharmacy closures will have significant consequences for both employees and other pharmacies.

PDA extends support for pharmacists as TESCO confirms pharmacy closures

TESCO to close 10 of its pharmacies later this year

gettyimages

The Pharmacists’ Defence Association (PDA) has raised concerns about the potential impact on employees following TESCO’s decision to close 10 of its pharmacies later this year.

The supermarket chain, which operates around 360 in-store pharmacies across the UK, has not yet confirmed which sites will be affected or the timeline for the closures.


Acknowledging that this uncertainty may cause some pharmacists “to feel anxiety over the future of their role and possible redundancies,” the PDA assured pharmacists that it will provide guidance and support to those impacted.

The retailer has assured patients that an alternative TESCO pharmacy will be available within a five-mile radius of any closing location.

However, the PDA argued that this could place additional strain on nearby pharmacies.

“Patient volume may migrate to other pharmacies depending on local circumstances. This may also mean more of a strain on these alternative pharmacies. This could even extend to other pharmacies outside of TESCO’s as patients try to find one that is more suitable and closer to them,” the PDA stated.

The PDA noted that many pharmacists have already expressed concerns about resource levels, suggesting that if patient numbers significantly increase, surrounding pharmacies will need additional resources, staffing and physical space on the premises to “safely cope with the increase in business.”

The association has advised pharmacy operators to plan ahead to ensure they are adequately resourced for any future increase in business due to Tesco closures.

For employees facing job loss, the PDA said it will do all it can for them.

It expects pharmacists to receive adequate redundancy compensation and fair treatment as they try and seek alternative employment during any notice period.

The PDA also highlighted the risk of redundancy and emphasised that employers should explore alternative options such as changing working hours, offering voluntary redundancy or moving employees into suitable alternative vacancies.

“Any proposed alternative needs to be suitable for the individual and their circumstances,” it said.

If no suitable alternative is available, a pharmacist’s role may become redundant.

The PDA’s redundancy factsheet outlines advises that those affected have the right to -

  • Request information from their employer such as the reason for redundancy, the number of proposed redundancies, the proposed selection procedure, the method and timescale of dismissals, and details of any agency workers being used.
  • Request reasonable time off to look for a new job or arrange training.
  • Ensure that their employer does not discriminate or act unlawfully in how they make their selection of who is made redundant.
  • Protection against discrimination or unlawful treatment in redundancy selection.

Pharmacists concerned about their employment status are encouraged to contact the PDA Member Support Centre for advice and assistance.

More For You

Medicine shortages: Penny-pinching costs taxpayers more, warns CCA

Pharmacies are forced to dispense medicines at a loss or face stock shortages.

Getty Images

Government’s penny-pinching approach driving medicine shortages, CCA warns

The Company Chemists’ Association (CCA) has warned the government's longstanding drive to save pennies on the medicines bill is leading to avoidable medicine shortages, ultimately costing taxpayers more.

In a newly released paper, the CCA highlighted how the government has squeezed the price it is willing to pay for many medicines, making the UK a less attractive market for pharmaceutical manufacturers and suppliers.

Keep ReadingShow less
Morrison: Pharmacy contract news

Janet Morrison

Morrison: Pharmacy contract news “before the start of the financial year”


Community pharmacies will get clarity over a new funding contract before the start of the financial year, according to Community Pharmacy England (CPE) chief executive Janet Morrison.

Keep ReadingShow less
Amanda Pritchard appointed chief executive of Guy's and St Thomas'

Amanda Pritchard appointed chief executive of Guy's and St Thomas'

Amanda Pritchard appointed chief executive of Guy's and St Thomas'

Amanda Pritchard, who is set to step down as NHS England chief in April, has been appointed as the next chief executive of Guy’s and St Thomas’ NHS Foundation Trust.

Pritchard previously led the Trust from October 2015 to August 2019 before moving to NHS England, where she later became its first female chief executive in August 2021.

Keep ReadingShow less
Confirm Pharmacy First Funding beyond April- Helen Morgan MP urges health secretary

North Shropshire MP Helen Morgan

Helen Morgan MP calls on Wes Streeting to clarify Pharmacy First’s future

Liberal Democrat health and care spokesperson Helen Morgan has urged the government to provide clarity on the future of Pharmacy First and confirm continued funding beyond April.

In a letter to health secretary Wes Streeting, the North Shropshire MP expressed deep concern over the uncertainty surrounding the initiative, which plays a crucial role in shifting healthcare services into communities.

Keep ReadingShow less
NHS England restructures leadership with new executive team

Except for the deputy chief executive officer, all team members will assume their roles on 1 April 2025.

Getty Images

NHS England announces new executive team to lead transformation

Sir James Mackey will be leading NHS England’s transition into the Department of Health and Social Care (DHSC), along with the incoming team.

He will officially take up the role as the new chief executive officer of NHS England on 1 April 2025, replacing Amanda Pritchard, who is stepping down at the end of this month.

Keep ReadingShow less